2021 annual financial data
Biodexa Pharmaceuticals 2021 Operating cash flow
Biodexa Pharmaceuticals 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -6,008,000 GBP.
Operating income was -6,998,000 GBP and net income was -5,460,000 GBP.
Operating cash flow was -6,008,000 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 578,000 GBP
- Operating income
- -6,998,000 GBP
- Net income
- -5,460,000 GBP
- Operating cash flow
- -6,008,000 GBP